Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Agenus Inc AGEN

Healthcare Biotechnology
Agenus Inc. is an immuno-oncology (I-O) company targeting cancer and infectious diseases with a pipeline of immunological agents. It is specialized in developing therapies to activate the body's immune system against cancer and infections. Its pipeline includes immune-modulatory antibodies, adoptive cell therapies (via MiNK Therapeutics, Inc.), and vaccine adjuvants (via SaponiQx, Inc.). Its... see more

Recent & Breaking News (NDAQ:AGEN)

Agenus Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before November 5, 2024 to Discuss Your Rights - AGEN

Accesswire October 23, 2024

AGEN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Investors Have Opportunity to Lead Class Action Lawsuit!

Accesswire October 23, 2024

AGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Agenus Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

PR Newswire October 23, 2024

Class Action Filed Against Agenus Inc. (AGEN) Seeking Recovery for Investors - Contact Levi & Korsinsky

Accesswire October 22, 2024

AGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Agenus Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

Accesswire October 22, 2024

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus

Accesswire October 22, 2024

Agenus Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - AGEN

Accesswire October 22, 2024

Agenus Inc Is Being Sued For Violating Securities Laws And Shareholders With Losses Are Urged To Contact The Schall Law Firm

Accesswire October 22, 2024

November 5, 2024 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against AGEN

Accesswire October 22, 2024

AGEN INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Investors Have Opportunity to Lead Class Action Lawsuit!

Accesswire October 22, 2024

Agenus Inc. Class Action: Levi & Korsinsky Reminds Agenus Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of November 5, 2024 - AGEN

Accesswire October 21, 2024

ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Agenus Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AGEN

Newsfile October 21, 2024

Contact Levi & Korsinsky by November 5, 2024 Deadline to Join Class Action Against Agenus Inc.(AGEN)

Accesswire October 21, 2024

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Agenus

Newsfile October 21, 2024

Agenus Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - AGEN

Accesswire October 21, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Agenus Inc. of Class Action Lawsuit and Upcoming Deadlines - AGEN

Accesswire October 21, 2024

The Schall Law Firm Encourages Investors To Join A Securities Fraud Case Against Agenus Inc.

Accesswire October 21, 2024

Agenus Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before November 5, 2024 to Discuss Your Rights - AGEN

Accesswire October 21, 2024

Lost Money on Agenus Inc.(AGEN)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

Accesswire October 21, 2024

AGEN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Agenus Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

Accesswire October 21, 2024